HEART FAILURE AND CHRONIC KIDNEY DISEASE POST-ICU

Clinical trials for HEART FAILURE AND CHRONIC KIDNEY DISEASE POST-ICU explained in plain language.

Never miss a new study

Get alerted when new HEART FAILURE AND CHRONIC KIDNEY DISEASE POST-ICU trials appear

Sign up with your email to follow new studies for HEART FAILURE AND CHRONIC KIDNEY DISEASE POST-ICU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope to stop heart and kidney decline after critical illness

Disease control Recruiting now

This study tests if a drug called dapagliflozin can protect the heart and kidneys of patients after they leave the intensive care unit (ICU). About 600 patients who were on life support in the ICU will take either the drug or a placebo pill daily for one year. Researchers will tr…

Matched conditions: HEART FAILURE AND CHRONIC KIDNEY DISEASE POST-ICU

Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Mar 30, 2026 14:27 UTC

HEART FAILURE AND CHRONIC KIDNEY DISEASE POST-ICU

Get alerted when new HEART FAILURE AND CHRONIC KIDNEY DISEASE POST-ICU trials appear

New hope to stop heart and kidney decline after critical illness